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Abstract- Biosensors are able to provide fast, accurate and 
reliable detections and monitoring of cancer cells, as well as to 
determine the effectiveness of anticancer chemotherapy agents 
in cancer treatments. These have attracted a great attention of 
research communities, especially in the capabilities of detecting 
the pathogens, viruses and cancer cells in narrow scale that the 
conventional apparatus and techniques do not have. This paper 
presents technologies and applications of biosensors for detec-
tions of cancer cells and related diseases, with the focus on the 
current research and technology development about biosensors 
in Vietnam, a typical developing country with a very high 
number of patients diagnosed with cancers in recent years, but 
having a very low cancer survival rate.  The role of biosensors 
in early detections of diseases, cancer screening, diagnosis and 
treatment, is more and more important; especially it is estimat-
ed that by 2020, 60-70% new cases of cancers and nearly 70% 
of cancer deaths will be in economically disadvantaged coun-
tries. The paper is also aimed to open channels for the potential 
R&D collaborations with partners in Vietnam in the areas of 
innovative design and development of biosensors in particular 
and medical technology devices in general. 
Keywords—Biosensor, DNA sensor, cancer, cancer cell, med-
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I. INTRODUCTION  
Biosensors are analytical devices used to detect the pres-
ence or concentration of a biological analyte, such as a bio-
molecule, a biological structure or a microorganism by es-
sentially converting a biological entity such as protein, DNA 
and RNA into an electrical signal that can be detected and 
analyzed. Biosensors consist of three parts: a component 
that recognizes the analyte and produces a signal, a signal 
transducer, and a reader device. Biosensors can be used to 
detect emerging cancer biomarkers and to determine drug 
effectiveness at various target sites; it has the potential to 
provide a fast and accurate detection, reliable imaging of 
cancer cells, and monitoring of angiogenesis and cancer 
metastasis, and the ability to determine the effectiveness of 
anticancer chemotherapy agents [1]. Today, biosensors play 
an important role in both diagnosis, monitoring, detection 
and effective treatments of diseases. This is more important 
for developing countries with low-income and poor medical 
services, where the cost of cancer treatments is high com-
pared to the income; especially more than half of all cancer 
cases and nearly 2/3rd of global cancer deaths occur in de-
veloping countries [2].  
This paper presents technologies and applications of bio-
sensors for detections of cancer cells and related diseases, 
with the focus on the current research and technology 
(R&D) development about biosensors in Vietnam, a typical 
developing country with a very high number of patients 
diagnosed with cancers in recent years, but having a very 
low cancer survival rate. The potentials for R&D collabora-
tions with Vietnamese partners are discussed and proposed. 
The rest of the paper is organized as follows. Section II 
presents about different types of biosensors, their working 
principles and applications, and these biosensors are widely 
studied and successfully developed for medical applications 
in Vietnam. The discussions are presented in Section III, 
with the focus on the cancers in Vietnam, and potentials for 
R&D collaborations about developments of biosensors for 
detection, diagnosis, monitoring, and effective treatments of 
cancers. Finally, Section IV presents a brief conclusion. 
II. BIOSENSORS STUDIED AND SUCCESSFULLY DEVELOPED IN 
VIETNAM - WORKING AND DETECTION PRINCIPLES 
Fundamentally, a biosensor has a biological element that 
acts as the sensor and an electronic element or transducer 
that detects and transmits the signal.  The biological element 
includes enzyme, antibody, living cells and biological tissue; 
it interacts with the analyte (target) being tested; and the 
biological response is converted into an electrical signal by 
the transducer which convert the non-electrical stimulus into 
electrical signal that can be added, multiplied, divided or 
amplified. Depending on the types of nonelectrical values 
that the electronic element can convert, the compatible elec-
tronic circuits are designed in a corresponding manner and 
finally displayed  in an easy and friendly way. This leads to 
different detection types of biosensors, including: Electro-
mechanical, mechanical and optical detections. 
A. Electrochemical detection 
Electrochemical biosensors are used to detect cancer bi-
omarkers or cancer cells. The electrochemical biosensors are 
most preferably studied and developed because the fabrica-
tion of these sensors is not difficult; and the readout circuit 
  
and the operational software can be designed, developed and 
coded conveniently.  However, the detection capability is 
limited to some applications. The transducer of this biosen-
sor can detect changes in electric properties like capacitance, 
resistance, current density and/or voltage of the interface 
between the media solution and the biological membrane 
that is immobilized on the surface of the transducer. 
 
 
 
 
 
 
 
 
 
Fig.1 Portable and multichannel equipment for DNA virus detection 
developed by BIOMAT and NIHE. 
The biomaterials and life science research group 
(BIOMAT) at Hanoi University of Science and Technology 
(HUST), Vietnam, has performed the conductance measur-
ing resulted by the hybridization between the probe and 
DNA target for herpes virus detection. The AC reference 
signals (10 KHz, 100 mV) produced by the Lock-in Ampli-
fier SR830 generator were applied on two interdigitated 
electrodes. The output signal was acquired by measuring the 
voltage drop on two 1 KΩ resistances using the A and B 
channels of the Lock-in Amplifier interfaced with a comput-
er. In order to improve the signal to noise ratio, differential 
measurements were employed. The DNA sensor detected 
the lowest DNA concentration of 2 nM [19].  
Figure 1 presents a portable and multichannel equipment 
for the DNA virus detection which was successfully devel-
oped by BIOMAT and National Institute for Hygiene and 
Epidemiology (NIHE), Vietnam, based on the electrochemi-
cal detection principles. A lot of effort has been made to 
improve the characteristics of the micro and nanobiosensor 
by shrinking the size of the transducer [20] or by sensor’s 
surface modification. For example, the DNA Sensor based 
on the multi-walled carbon nanotubes could detect 0.5 nM 
of the target DNA samples and the response time of the 
DNA sensor is approximately 4 minutes [3,4]. Various im-
pact parameters on the hybridization of probe/target DNA 
such as the hybridization temperature, probe concentration, 
mismatch target and hybridization time was also investigat-
ed [5]. The characteristics of the DNA sensor could also be 
improved by creating the nanostructure, such as the polypyr-
role (PPy) nanowires, on the surface of a transducer.  
The electrochemical detection can also be realized by us-
ing a cyclic voltammetry, amperometry or potentiostat in 
both open and narrow spaces. These techniques are general-
ly conducted by changing the applied voltage to the trans-
ducer and measuring the change in current or current density 
that is generated by the biochemical reaction of the biologi-
cal elements [6-10]. L.H Nguyen and teams at HUST, Vi-
etnam Academy of Science and Technology, Institute for 
Tropical Technology (Vietnam), developed electrochemical 
biosensors using the cyclic voltametry technique for the 
DNA sensor applications [11]. The technique was also ap-
plied for the label-free detection of Carcino-Embryonic 
Antigens (CEA) [12], and for determination of the residual 
pesticide in water [13] using the poly (methyl methacrylate) 
(PMMA) microfluidic device. In addition to the cyclic vol-
tametry, the Electrochemical Impedance Spectroscopy (EIS) 
was also employed for determination of the human Chorion-
ic Gonadotropin (hCG) using disposable screen-printed 
electrodes [14]. 
B. Mechanical detection 
The mechanical detection is normally applied for the 
transducer of a biosensor that senses with the mechanical 
properties of the materials. In general, the transducers are 
developed using the materials that exhibit the piezoelectric 
effect. Quartz (SiO2) crystal is the most well-known in 
developing piezoelectric effect-based transducers. Lien 
T.T.N and teams at HUST, Hue University (Vietnam), Japan 
Advanced Institute of Science and Technology (Japan) and 
Korea University (Korea) have modified the surface of a 
Quartz Crystal Microbalance (QCM) with multi-walled 
Carbon Nanotube (MWCNTs)-doped polypyrrole (PPy) for 
the detection of genetically modified organism (GMO) [15].  
Regarding the micromachining fabrication, Hien Duy Tong 
and his teams in the Netherlands and Spain developed the 
arrays of small nanomechanical resonators with a dual ge-
ometry for the DNA detection based on Watson-Crick pair-
ing rules [16]. He also reported the isolation and characteri-
zation of the cells by employing the microwell chip [17]. 
C. Optical detection 
Compared to the electrochemical detection, there are a 
few research groups who develop biosensors in which the 
readout is a photo/optical signal; although this kind of tech-
nique has lowest LOD and most reliable. In Vietnam, 
BIOMAT has been developing the fluorescence base assays 
based on the optical detection principles. The system con-
sists of the light source, a fluorescence detector; an antigen 
ready strip that is fixed on the sample holder. The samples 
(the blood) are deposited on to a strip in which the surface is 
modified and functionalized with the dye-antibody. Then the 
specific binding between the antigen (in the sample) and the 
immobilized antibody (on the strip) will occur. A laser 
source with the matching wavelength illuminates on the strip 
and emits the scattering light with corresponding wave-
length (photoluminescence in this case). By comparison of 
the emission density (photoluminescence) given be the sam-
ple on the strip and that of the control sample, the analysis 
will let the operator know if the sample is positive or nega-
tive (see Fig.2). BIOMAT has carried out the design and 
  
 
realization of the optical filter via deposition of different 
layers of materials on a surface of a substrate, using the 
electron beam ion-assisted deposition technique.  
 
 
 
 
 
 
 
Fig.2 The dye can emit photoluminescence by the UV exciting light. 
In addition, BIOMAT has an initial success in creating a 
new coumarin derivative based biomarker by the combina-
tion of a coumarin skeleton that contains 7-diethylamnion as 
an electron-donating group with the fused polycyclic sulfur-
containing aromatic rings. The dye is soluble in the water or 
in hybrid solvent; biocompatible; and shows a strong fluo-
rescence at room temperature, with the emission wavelength 
at 508 nm (the visible green light, Fig.2) with a very large 
Stokes’ shift (more than 100 nm) [17].  The optical sensor 
based on the microwell was successfully developed by 
HUST and its partners for detecting the prostate cancer cells 
which were stained in such a way that they were visible by 
the fluorescence microscope [18]. 
III. POTENTIALS  OF BIOSENSORS FOR CANCER SCREENING 
AND DETECTION IN VIETNAM 
Patients diagnosed with cancers have been rapidly in-
creasing in Vietnam in recent years. Many oncology clinics 
and hospitals in Vietnam were newly established to solve 
the problems of limited resources and facilities that have not 
met well the treatment demand. According to recent reports, 
especially the talk given by National Cancer Hospital (K 
Hospital) ) in Hanoi at The 9th session of the Joint Vietnam-
US Committee on Scientific and Technological Cooperation 
(JCM-9) that took place in Ho Chi Minh City on December 
2nd 2015, Vietnam is now ranked the 12th in the incidence 
(2.6/100,000) and death (1.0/100,000) about cancer diseases. 
Annually, there are nearly 125 thousand people who are 
diagnosed with the cancers in Viet Nam. K Hospital opened 
two more additional campuses; and 3 campuses have totally 
1,540 beds. The number of patients coming for the cancer 
examinations in 2014 was 230,388 of which the number 
coming for the cancer treatments was 42,289.  
There have been lots of efforts from research communi-
ties in Vietnam who have been working on developments of 
innovative and cost-effective solutions for early detection 
and screening as well as monitoring, diagnosis and treat-
ments of cancers. Currently, the conventional methods for 
early stage cancer screening are mammogram, Magnetic 
resonance imaging (MRI), Human papillomavirus (HPV) 
testing, Low-dose helical or spiral computed tomography 
(CT) scan, Digital rectal examination (DRE), Positron Emis-
sion Tomography and Computed Tomography (PET-CT) 
Scans. The common point of these methods is that, in most 
cases, the expenditure for the medical test is more than the 
medical insurance coverage. In addition, the cost of cancer 
treatments has increased dramatically; fore example, the 
total direct medical cost for a 5-year treatment course for 
breast cancer in central Vietnam was estimated at $975 per 
patient [22]. The cancer treatment is expensive for most of 
the patients; this is a big concern in Vietnam, a typical de-
veloping country, with the GDP per capita of 1077.91 USD 
(2014).  Therefore, there is an urgent need for a multidisci-
plinary approach and cost-effective solutions to improve 
early detections of cancers and quality of cancer screening 
services and cancer care, diagnosis and treatments as well as 
rehabilitation and supportive-care facilities.  
IV. DISCUSIONS AND CONCLUSION 
For the last decade, the medical device market in Vi-
etnam has been increasing consecutively. The imported 
medical devices in Vietnam cover more than 90% of the 
market. According to the estimation of Espicom [21], the 
Vietnamese medical device market is expected to increase 
by 7.0% in US dollar terms in 2016. Vietnam is becoming a 
manufacturing location for medical device companies and 
exports with the consistent growth, the medical device mar-
ket will remain one of the strongest performers in the Asia 
Pacific region.  The analysis of Espicom also projects that 
the market will expand at a 2014-2019 CAGR of 7.9% in 
US dollar terms, ranging from 10.9% for orthopedics’ and 
prosthetics to 4.3% for other medical devices. The market is 
forecasted to increase from USD748.9mn in 2014 to USD 
1,095.1 mn in 2019.The import performance is expected to 
improve in 2016, with the economy remaining strong and 
healthcare expenditure rising each year in line with the ex-
pansion of national health insurance coverage and other 
healthcare programs. In the 12 months to August 2015, 
imports of medical devices increased by 0.7% in US dollar 
terms to USD 662.2 mn.  For 12 months from August 2014 
to August 2015, the exports of medical devices from Vi-
etnam increased by 9.1% in US dollar terms to USD 
766.5mn. With new production companies, such as the 
United Healthcare plant in Ho Chi Minh City, and continu-
ing collaborations between Vietnamese and foreign compa-
nies; it is believed that exports of medical devices will con-
tinue to grow in coming years. Table 1 shows the Vietnam’s 
potential market of medical devices in the coming years. In 
addition, it is estimated that by 2020, 60-70% new cases of 
cancer and nearly 70% of cancer deaths will be in economi-
cally disadvantaged countries. Therefore, there is an emerg-
  
ing need for investments on cost-effective and innovative 
developments of medical products and services for the can-
cer scanning, detection, diagnosis and treatments. This 
opens potential collaborations for R&D between research 
institutions in Vietnam and other countries, especially the 
multi-collaborations among scientist and experts in the areas 
of medicine, biomaterials, micro-electronics, intelligent 
computing, biomechanics, micro and nano manufacturing, 
lab-on-chips,  medical image processing, and telehealth.   
Table 1 - Projected Medical Device Market, 2014-2019 [21] 
Year Total 
(USD mn) 
Per Capita 
(USD) 
Total  
(VND) 
Per Capita 
(VND mn) 
 
2014 748.9 8.1 15,876,864.8 171,552.8 
2015 781.8 8.4 16,783,679.5 179,722.5 
2016 836.8 8.9 17,949,212.8 190,561.8 
2017 913.7 9.6 19,415,281.9 204,453.8 
2018 999.4 10.4 21,036,813.9 219,828.3 
2019 1,095.1 11.4 22,833,766.9 236,876.8 
 
Biosensors, especially the DNA sensors and immunosen-
sors, should be promising candidates for R&D collabora-
tions to develop cost-effective solutions for cancer scanning, 
detection, diagnosis and treatments, due to its sensitivity, 
selectivity, response time and reasonable prices. Since can-
cer screening requires a very Low Limit of Detection (LOD) 
that may be hard to overcome using electrochemical detec-
tion techniques. Meanwhile the optical detection seems to 
have a much better LOD.  Therefore, we propose to innova-
tively and cost-effectively develop immunosensors via the 
integration of electrochemical microfluidics and optical 
sensors, and the use of synthesized biomarkers. Finally, the 
cost-effective solutions via the use of telehealth and lab-on-
chips for screening and early detections of diseases should 
be the core R&D objectives, especially for the developing 
and low-income countries. The key to fighting cancer also 
lies in the early detection and prediction of the decease using 
the proposed technology. 
ACKNOWLEDGEMENT 
Colleagues and PhD students at HUST are acknowledged for 
their contributions. British Council – Newton Fund is acknowl-
edged for their support. 
REFERENCE 
1. Brian B. and Shaker A.M (2010) Biosensors: the new wave in cancer 
diagnosis. Nanotechnol Sci Appl. 2011: 4: 1–10 
2. J. Ferlay et al. (2012) Cancer incidence and mortality worldwide: 
sources, methods and major patterns in GLOBOCAN 2012, Int. J. 
Cancer 136 (5): e359–e386 
3. P.D Tam et al. (2009) DNA sensor development based on multi-wall 
carbon nanotubes for label-free inﬂuenza virus (type A) detection, 
Journal of Immunological Methods; 350:118–124 
4. T.T Nguyen et al. (2012) Detection of pathogenic microorganisms 
using biosensor based on multi-walledcarbon nanotubes dispersed in 
DNA solution, Current Applied Physics; 12(6): 1553–1560 
5. D.T Phuong et al. (2009) Impact parameters on hybridization process 
in detecting inﬂuenza virus (type A) using conductimetric-based DNA 
sensor, Physica E41; 1567–1571 
6. D.B Bui and A.T Mai (2013) Electrochemical synthesis of 
polypyrrole for biosensor application, Int. J. Nanotechnology; 10: 
154-163 
7. V.T Chuet al. (2013) Polyaniline Nanowires-Based Electrochemical 
Immunosensor for Label Free Detection of Japanese Encephalitis 
Virus, Analytical Letters; 46:1229–1240 
8. A.T Mai et al. (2014) Highly sensitive DNA sensor based on polypyr-
role nanowire, Applied surface science;309:0169-4332 
9. T.L Tran et al. (2014) Effective immobilization of DNA for develop-
ment of polypyrrole nanowires based biosensor, Applied surface sci-
ence; 314:260-265 
10. T.L Tran et al. (2015) In-channel-grown polypyrrole nanowire for the 
detection of DNA hybridization in an electrochemical microfluidic 
biosensor, Journal of Nanomaterials; ID 458629 
11. L.H Nguyen et al. (2014) Functionalization of reduced graphene 
oxide by electroactive polymer for biosensing applications, Adv. Nat. 
Sci.: Nanosci. Nanotechnol; 5:035005 
12. V.A Nguyen  et al. (2016) Development of a PMMA Electrochemical 
Microfluidic Device for Carcinoembryonic Antigen Detection, Jour-
nal of Electronic Materials; 45:2455-2462 
13. H.V. Tran et al. (2012) A label-free electrochemical immunosensor 
for direct, signal-on and sensitive pesticide detection, Biosensors and 
Bioelectronics; 31: 62-68 
14. Lien TTN et al. (2011) Development of Label-Free Impedimetric 
Hcg-Immunosensor Using Screen- Printed Electrode. J Biosens Bioe-
lectron; 85(5):2576-80 
15. T.N.L Truong et al. (2010) Multi-wall carbon nanotubes (MWCNTs)-
doped polypyrrole DNA biosensor for label-free detection of genet-
ically modified organisms by QCM and EIS, Talanta; 80:1164-1169. 
16. D. Ramos et al. (2009) (2009) Arrays of Dual Nanomechanical Reso-
nators for Selective Biological Detection. Anal. Chem; 81: 2274-2279 
17. Q.T Tran et al. (2015) Synthesis of Coumarin Derivatives Based 
Fluorescent Dye Towards the Detection of Cancer Cell, Vietnam 
Journal of Chemistry;53(5):641-646 
18. J.F Swennenhuis et al. (2015) Self-seeding microwell chip for the 
isolation and characterization of single cells, Lab Chip;15: 3039-3046 
19. P.D Tam et al. (2010) Facile preparation of a DNA sensor for rapid 
herpes virus detection, Materials Science and Engineering C30; 1145–
1150 
20. P.T Tam et al. (2011) Design and fabrication study of DNA sensor 
based on the integrated electrode arrays, The 3rd international 
workshop on nanotechnology and application, 2011, pp. 563-566 
21. Vietnam Medical Devices Report: www.espicom.com [Access: April 
2016] 
22. Hoang Lan N et al. (2013) Cost of treatment for breast cancer in 
central Vietnam. Glob Health Action; 4 (6):18872 
23. Miriam L.G. et al.  (2013) Cancer in developing countries: The next 
most preventable pandemic. The Global problem of cancer. Critical 
Reviews in Oncology/Hematology;  88:117–122 
 
Author:    Mai Anh Tuan 
Institute:  Hanoi University of Science and Technology 
Address:  No. 1, Dai Co Viet  Street 
City:          Hanoi 
Country:  Vietnam 
Email:       tuan.maianh@hust.edu.vn 
